Alerts will be sent to your verified email
Verify EmailSOLARA
|
Solara Active Pharma
|
Morepen Laboratories
|
Aarti Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Manufacturing Capacity - Ibuprofen
|
5000.0 MTPA | n/a | n/a |
|
US DMF Filings
|
230.0 . | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
2.8 % | 13.43 % | 18.02 % |
|
5yr average Equity Multiplier
|
1.99 | 1.68 | 1.97 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 1.29 | 1.09 |
|
5yr Avg Net Profit Margin
|
-7.28 % | 5.93 % | 8.24 % |
|
Price to Book
|
2.21 | 1.97 | 2.24 |
|
P/E
|
0.0 | 23.72 | 17.84 |
|
5yr Avg Cash Conversion Cycle
|
28.67 Days | 12.78 Days | 79.88 Days |
|
Inventory Days
|
111.94 Days | 54.64 Days | 69.48 Days |
|
Days Receivable
|
95.97 Days | 65.45 Days | 111.3 Days |
|
Days Payable
|
146.85 Days | 96.29 Days | 97.75 Days |
|
5yr Average Interest Coverage Ratio
|
0.25 | 39.11 | 9.61 |
|
5yr Avg ROCE
|
2.1 % | 15.77 % | 21.16 % |
|
5yr Avg Operating Profit Margin
|
9.63 % | 8.68 % | 14.01 % |
|
5 yr average Debt to Equity
|
0.7 | 0.04 | 0.46 |
|
5yr CAGR Net Profit
|
-69.98 % | 3.98 % | -9.72 % |
|
5yr Average Return on Assets
|
-3.67 % | 7.67 % | 9.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
42.0 % | 35.65 % | 55.03 % |
|
Share Pledged by Promoters
|
31.57 % | 0.0 | 2.47 % |
|
Change in Promoter Holding (3 Yrs)
|
1.03 % | -2.57 % | -4.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.03 % | 0.0 | 6.13 % |
|
Solara Active Pharma
|
Morepen Laboratories
|
Aarti Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|